# Antoinette Cheung

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/antoinette-cheung/

## Facts

| Field | Value |
| --- | --- |
| Citations | 515 |
| Field | Complement system in diseases |
| h-index | 9 |
| i10-index | 9 |
| OpenAlex ID | https://openalex.org/A5001149424 |
| ORCID iD | 0000-0003-0335-6611 |
| Works | 38 |

## Researcher papers

- [Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review](https://scholariq.org/papers/serum-uric-acid-and-the-risk-of-incident-and-recurrent-gout-a-systematic-review/)
- [A review of published anticholinergic scales and measures and their applicability in database analyses](https://scholariq.org/papers/a-review-of-published-anticholinergic-scales-and-measures-and-their/)
- [Incidence of acute care adverse events and long-term health-related quality of life in patients with TSCI](https://scholariq.org/papers/incidence-of-acute-care-adverse-events-and-long-term-health-related-quality-of/)
- [Use of the Spine Adverse Events Severity System (SAVES) in patients with traumatic spinal cord injury. A comparison with institutional ICD-10 coding for the identification of acute care adverse events](https://scholariq.org/papers/use-of-the-spine-adverse-events-severity-system-saves-in-patients-with-traumatic/)
- [A US cost-minimization model comparing ravulizumab versus eculizumab for the treatment of atypical hemolytic uremic syndrome](https://scholariq.org/papers/a-us-cost-minimization-model-comparing-ravulizumab-versus-eculizumab-for-the/)
- [Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab](https://scholariq.org/papers/cost-burden-of-breakthrough-hemolysis-in-patients-with-paroxysmal-nocturnal/)
- [Progression to Loss of Ambulation Among Patients with Autosomal Recessive Limb-girdle Muscular Dystrophy: A Systematic Review](https://scholariq.org/papers/progression-to-loss-of-ambulation-among-patients-with-autosomal-recessive-limb/)
- [Reliability of the spine adverse events severity system (SAVES) for individuals with traumatic spinal cord injury](https://scholariq.org/papers/reliability-of-the-spine-adverse-events-severity-system-saves-for-individuals/)
- [Impact of Caring for Individuals With Heart Failure in the United States](https://scholariq.org/papers/impact-of-caring-for-individuals-with-heart-failure-in-the-united-states/)
- [Onset, Risk Factors, and Impact of Delirium in Patients with Traumatic Spinal Cord Injury](https://scholariq.org/papers/onset-risk-factors-and-impact-of-delirium-in-patients-with-traumatic-spinal-cord/)

## Researcher topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Muscle Physiology and Disorders](https://scholariq.org/topics/muscle-physiology-and-disorders/)
- [Spinal Cord Injury Research](https://scholariq.org/topics/spinal-cord-injury-research/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Meta-analysis and systematic reviews](https://scholariq.org/topics/meta-analysis-and-systematic-reviews/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.